Nanobiotix (NBTX) Cash & Equivalents: 2019-2025

  • Nanobiotix's Cash & Equivalents fell 54.34% to $32.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $32.6 million, marking a year-over-year decrease of 54.34%. This contributed to the annual value of $53.1 million for FY2024, which is 34.73% down from last year.
  • As of Q2 2025, Nanobiotix's Cash & Equivalents stood at $32.6 million, which was down 38.62% from $53.1 million recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's Cash & Equivalents peaked at $123.2 million during Q2 2021, and registered a low of $23.6 million during Q2 2023.
  • In the last 3 years, Nanobiotix's Cash & Equivalents had a median value of $53.1 million in 2024 and averaged $52.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 64.98% in 2023, then skyrocketed by 203.30% in 2024.
  • Quarterly analysis of 5 years shows Nanobiotix's Cash & Equivalents stood at $96.0 million in 2021, then slumped by 45.43% to $67.2 million in 2022, then crashed by 64.98% to $81.0 million in 2023, then slumped by 34.38% to $53.1 million in 2024, then crashed by 54.34% to $32.6 million in 2025.
  • Its Cash & Equivalents was $32.6 million in Q2 2025, compared to $53.1 million in Q4 2024 and $71.4 million in Q2 2024.